Barclays Downgrades Johnson & Johnson (JNJ) to Equalweight

November 29, 2016 6:44 AM EST
Get Alerts JNJ Hot Sheet
Price: $112.26 +1.14%

Rating Summary:
    9 Buy, 16 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade JNJ Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

(Updated - November 29, 2016 8:08 AM EST)

Barclays downgraded Johnson & Johnson (NYSE: JNJ) from Overweight to Equalweight with a price target of $125.00 (from $130.00). Analyst Geoff Meacham sees less compelling risk-reward.

For an analyst ratings summary and ratings history on Johnson & Johnson click here. For more ratings news on Johnson & Johnson click here.

Shares of Johnson & Johnson closed at $113.13 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change, Downgrades

Related Entities


Add Your Comment